Investors

Computer Vision AG addresses the global bottleneck in medical diagnostics with its Emeralgo software.

The number of MRI examinations is rising rapidly worldwide, while the shortage of radiologists is putting increasing pressure on care. At the same time, specialists are spending a significant amount of time on manual measurements, documentation and repetitive reporting workflows.

Emeralgo automates these processes directly in the clinical workflow: our clinically validated AI creates structured reports and integrates them seamlessly into existing PACS systems. This enables clinics to increase their diagnostic capacity, significantly reduce reporting time and achieve measurable economic added value.

Market potential in a market worth billions

With musculoskeletal (MSK) imaging, we are addressing the fastest-growing segment in radiology. The total global market for MRI examinations is worth around USD 100 billion, with orthopaedics alone accounting for a volume of USD 25 billion. Over 100 million MRI scans are performed worldwide every year, of which around 25% are for the spine - a segment that alone generates costs of USD 24 billion.

The Imaging Diagnostics AI market potential is immense: analysts forecast this specific sector to grow to up to USD 19.8 billion by 2033 at a compound annual growth rate (CAGR) of up to 34%. Emeralgo is positioned precisely at the interface between massive clinical demand and exponential market growth.

Global radiology is on the verge of collapse: a drastic shortage of specialists is meeting a rapidly growing volume of examinations. The market for MRI examinations alone is worth USD 100 billion worldwide, with the musculoskeletal (MSK) imaging segment forming the heart of orthopaedics at USD 25 billion.

While others offer point solutions for niches, Computer Vision AG is building a vendor-independent software with Emeralgo. We address over 100 million MRI scans annually, which are still painstakingly analyzed manually today. Our goal is clearly defined: Market leadership in MSC MRI diagnostics through a platform that makes expert knowledge available anytime, anywhere.

The decisive moment for an investment: Why now?

Global radiology is facing a critical bottleneck. An acute shortage of specialist radiologists meets an exploding demand for MRI examinations, driven by an ageing population and more active lifestyles. Specialists now spend up to 30 minutes per case on routine manual measurements, pushing the healthcare system to its limits.

This is exactly where Emeralgo comes in, freeing medical diagnostics from human capacity limits.

Regulatory breakthrough: With the US FDA approval for our lumbar spine module, we have cleared the technological hurdle and are on the verge of a global rollout.
Massive economic leverage: Our clinically validated AI reduces diagnostic time by up to 50 %. For clinics, this means an ROI of 30:1 - every franc invested can save up to 30 francs in labor costs.
Scaling to global market leadership: We are developing the world's first "one-stop store" for the entire orthopaedics sector (spine, knee, shoulder, hip).

Use this window of opportunity to invest in a highly scalable Swiss technology platform for a 100 billion dollar market.

Clinically validated. Regulatory validated. Ready for the market.

We are not a research project, but a company at an operational turning point. Our lumbar spine module already has the prestigious US FDA 510(k) clearance, giving us access to the most important radiology market in the world. The technological superiority is proven by four independent, peer-reviewed studies by Swiss universities, which confirm our expert-level precision.

With an investment base of already CHF 21 million and a team led by AI pioneer René Balzano (MSc ETHZ), we have successfully completed the high-risk development phase.

Our scaling logic follows a clear path to market leadership: "One signature, access to everything". While competitors often offer isolated point solutions, we are building a genuine "one-stop store" for orthopaedics with Emeralgo.

Successful market entry with the FDA-approved lumbar spine module (L-Spine).
Successive expansion of the suite to include modules for the knee, shoulder and hip by 2027/2028
Establishment of a global, manufacturer-independent AI platform that is seamlessly integrated into every hospital PACS.

Testimonials

Voices from the field. Experiences that create trust.

"Today, we use high-tech to create image scans, but we rely on decades of human experience to interpret them. With artificial intelligence, we will use technology to digitally support diagnostic processes"

Prof. Dr. med. Christian Pfirrmann, MDSpecialist in radiology, Medical Radiology Institute

"I expect that the use of artificial intelligence will enable me to evaluate scans more quickly so that I have more time for my patients."

Dr. Norbert Stauder, MDSpecialist in radiology and cardiac radiology, RNR Institute of Radiology and Neurology

"Emergency patients will receive a timely diagnosis. And patients in underserved areas will have access to high-quality radiology findings as quickly as possible."

Dr. Michael Borunda, MDUS emergency physician